Merck Animal Health Ventures

Merck Animal Health is a global, research-driven company that develops, manufactures, and markets a wide range of veterinary medicines and services. The company offers an innovative portfolio designed for the prevention, treatment, and control of diseases affecting all major farm and companion animal species. With a presence in over 50 countries and products marketed in more than 140 countries, Merck Animal Health operates a comprehensive network of manufacturing sites and research and development facilities worldwide. The company prioritizes customer satisfaction by delivering high-quality, solutions-driven products and services aimed at supporting veterinarians, producers, and animal owners. Through its commitment to quality, professionalism, and integrity, Merck Animal Health seeks to become the partner of choice in the veterinary sector, ultimately contributing to the health of pets and livestock while ensuring a safe and affordable food supply.

Stephen Murray

Lead, Animal Health Ventures and Assistant Vice President

12 past transactions

Vence

Acquisition in 2022
Vence is a company that has developed a livestock management platform designed to enhance the control and management of cattle. Their innovative solution combines hardware, such as sensors and GPS technology, with application software, allowing farmers to remotely manage their livestock through virtual fencing. This technology enables farmers to optimize the use of available grazing land by increasing the number of animals on a farm while simultaneously reducing costs associated with traditional fencing and labor for moving animals. Additionally, Vence's platform provides valuable insights into animal behavior, health, and fertility, ultimately helping livestock breeders improve efficiency and increase protein yield.

Targan

Series C in 2022
TARGAN is a bio-systems company dedicated to enhancing animal health and productivity in the poultry, livestock, and aquaculture sectors. It is developing an innovative vaccination system that aims to replace traditional mass spray methods with a more precise approach, ensuring that every newly hatched chick receives the appropriate vaccine. This technology not only aims to improve immunization rates but also enhances the natural immune response to diseases, leading to better overall flock health. By increasing vaccination accuracy and consistency, TARGAN's solution helps reduce reliance on antibiotics, contributing to cleaner and healthier livestock. The company's focus on improving animal well-being and operational efficiency positions it as a leader in the field of animal production.

Vence

Series A in 2022
Vence is a company that has developed a livestock management platform designed to enhance the control and management of cattle. Their innovative solution combines hardware, such as sensors and GPS technology, with application software, allowing farmers to remotely manage their livestock through virtual fencing. This technology enables farmers to optimize the use of available grazing land by increasing the number of animals on a farm while simultaneously reducing costs associated with traditional fencing and labor for moving animals. Additionally, Vence's platform provides valuable insights into animal behavior, health, and fertility, ultimately helping livestock breeders improve efficiency and increase protein yield.

Targan

Series B in 2021
TARGAN is a bio-systems company dedicated to enhancing animal health and productivity in the poultry, livestock, and aquaculture sectors. It is developing an innovative vaccination system that aims to replace traditional mass spray methods with a more precise approach, ensuring that every newly hatched chick receives the appropriate vaccine. This technology not only aims to improve immunization rates but also enhances the natural immune response to diseases, leading to better overall flock health. By increasing vaccination accuracy and consistency, TARGAN's solution helps reduce reliance on antibiotics, contributing to cleaner and healthier livestock. The company's focus on improving animal well-being and operational efficiency positions it as a leader in the field of animal production.

SomaDetect

Series A in 2021
SomaDetect Inc. is an agricultural technology company based in Fredericton, Canada, that focuses on providing dairy farmers with real-time analytics of milk components. Founded in 2016, the company has developed advanced sensor technology capable of measuring critical indicators such as fat content and somatic cell counts in milk. This innovative system enables farmers to conduct automated analysis without the need for chemicals or consumables, allowing them to identify issues early, manage herd health, and optimize milk quality. By delivering detailed insights during every milking, SomaDetect supports farmers in making informed decisions that enhance production while reducing unnecessary antibiotic use and ensuring high-quality milk enters the bulk supply.

Poultry Sense

Acquisition in 2021
Poultry Sense provides farmers with proven hardware and software technology solutions capable of capturing real-time data to increase transparency and accurately inform on-farm decision making. Poultry Sense’s unique data-driven offer uses wireless sensors to monitor environmental and health parameters paired with veterinary insight and analysis to identify areas of improvement in order to drive broiler bird performance and productivity.

Quantified Ag

Acquisition in 2020
Quantified Ag is a technology company that offers cloud-based sensors and a data platform for the cattle industry. The company's technology helps dramatically reduce costs by lowering re-treatment rate and death loss and getting animals back to peak performance faster. It provides state of the art sensors and software subscription to livestock producers throughout the concentrated feeding industries. Quantified Ag was founded in June 2014 and is based in Lincoln, Nebraska, United States.

Targan

Series A in 2019
TARGAN is a bio-systems company dedicated to enhancing animal health and productivity in the poultry, livestock, and aquaculture sectors. It is developing an innovative vaccination system that aims to replace traditional mass spray methods with a more precise approach, ensuring that every newly hatched chick receives the appropriate vaccine. This technology not only aims to improve immunization rates but also enhances the natural immune response to diseases, leading to better overall flock health. By increasing vaccination accuracy and consistency, TARGAN's solution helps reduce reliance on antibiotics, contributing to cleaner and healthier livestock. The company's focus on improving animal well-being and operational efficiency positions it as a leader in the field of animal production.

Quantified Ag

Corporate Round in 2018
Quantified Ag is a technology company that offers cloud-based sensors and a data platform for the cattle industry. The company's technology helps dramatically reduce costs by lowering re-treatment rate and death loss and getting animals back to peak performance faster. It provides state of the art sensors and software subscription to livestock producers throughout the concentrated feeding industries. Quantified Ag was founded in June 2014 and is based in Lincoln, Nebraska, United States.

Prondil

Acquisition in 2017
Prondil S.A. is a biotechnology company based in Montevideo, Uruguay, specializing in the development and manufacturing of veterinary vaccines for livestock. Established in 1992, Prondil focuses on producing a variety of antigens and vaccines aimed at the active immunization of cattle, sheep, horses, goats, and other animals. These products are designed to prevent serious diseases such as gas gangrene, enterotoxaemia, blackleg, and infectious necrotic hepatitis, thereby enhancing animal health and welfare. The company provides support to technicians, veterinarians, and livestock producers who utilize its products. In December 2017, Prondil became a subsidiary of Merck Animal Health, which further strengthened its capabilities in the animal health sector.

Vallée S/A

Acquisition in 2016
Vallée S.A. is a Brazilian company specializing in the manufacture and distribution of vaccines, therapeutics, and supplements for veterinary use. Its product offerings cater to a variety of animals, including cattle, horses, swine, goats, sheep, and birds. Founded in 1961 and based in Montes Claros, Vallée S.A. originally operated under the name Vallée Nordeste S.A. before rebranding in 1990. The company has established itself as a key player in the animal health sector, serving both the domestic market and international clients. As of March 2017, Vallée S.A. operates as a subsidiary of Merck Sharp & Dohme Saude Animal Ltda.

Abmaxis

Acquisition in 2006
Abmaxis, Inc., a biopharmaceutical company, engages in the discovery, optimization, and development of monoclonal antibody (MAb) products for human therapeutics and diagnostics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.